FTC probing J & amp;J over arthritis drug Remicade

The organization issued a civil investigative demand to the drugmaker to see if its biosimilar defense strategy violates federal antitrust laws.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news